Semax is one of the most studied nootropic peptides in the world. Developed in Russia and used clinically for stroke recovery and cognitive disorders, it’s now gaining global attention for its effects on brain function.
What Is Semax?
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). The name comes from the Russian for “seven amino acids” (СЕМь АминоКиСлот).
Unlike its parent hormone ACTH, Semax has no effect on cortisol or stress hormones. Instead, it was engineered specifically for its cognitive and neuroprotective properties.
Semax is on the Russian List of Vital & Essential Drugs and is used clinically for stroke, transient ischemic attack, memory disorders, optic nerve disease, and immune support.
How Semax Works
BDNF Upregulation
This peptide rapidly increases brain-derived neurotrophic factor (BDNF).
Research shows a single dose of Semax produces:
- 1.4-fold increase in BDNF protein levels
- 1.6-fold increase in TrkB receptor phosphorylation
- 3-fold increase in BDNF mRNA expression
Dopamine & Serotonin Modulation
It activates dopaminergic and serotonergic systems in the brain:
- Dopamine drives motivation and reward-based learning
- Serotonin helps overcome the “aversive costs” of cognitive effort
Studies show it can also potentiate the effects of dopamine-releasing compounds.
Intracellular Calcium Dynamics
A 2025 study found this peptide significantly increases the frequency of spontaneous calcium fluctuations in hippocampal pyramidal neurons – providing insight into how it affects neuronal networks.
Enkephalin Protection
Like its cousin Selank, it inhibits enzymes that degrade enkephalins – natural peptides involved in mood and pain regulation.
What Semax Research Shows
Semax for Cognitive Enhancement
Studies demonstrate Semax improves:
- Learning and memory – increased conditioned avoidance reactions in animal models
- Attention and focus – improved scores on cognitive tests in humans
- Information processing – faster and more accurate cognitive performance
Researchers attribute these effects to modulation of the hippocampal BDNF/TrkB system. For another peptide targeting brain connectivity, explore Dihexa.
Semax in Stroke Recovery
It has extensive research in ischemic stroke:
- A 1997 study showed improved neurological function in stroke patients
- Animal studies demonstrate reduced brain damage and improved functional recovery
- A 2017 study found stroke patients treated with Semax (6000 µg/day for 10 days) had increased plasma BDNF and improved rehabilitation timing
Semax for Neuroprotection
It modulates over 1,500 genes related to:
- Immune response
- Vascular function
- Neuroplasticity
- Inflammation
This comprehensive gene expression modulation underlies its neuroprotective effects.
Mood & ADHD
- A 2024 study showed Semax combined with another ACTH analog reduced depressive symptoms and increased brain BDNF
- A 2010 study found it normalized anxiety and depression-related behavior in rats
- Researchers have proposed it as a potential non-stimulant approach for ADHD due to its effects on dopamine and BDNF
Semax vs. Selank
Both are Russian-developed peptides with nootropic properties, but they differ:
| Feature | Semax | Selank |
|---|---|---|
| Derived from | ACTH (4-10) | Tuftsin |
| Primary effect | Cognitive enhancement, neuroprotection | Anxiolytic, anti-anxiety |
| BDNF effects | Strong upregulation | Moderate |
| Dopamine effects | Strong activation | Moderate |
| Best for | Focus, learning, stroke recovery | Anxiety, stress, calm focus |
Many researchers study them together for complementary effects. Read more about Selank in our detailed guide.
Semax Safety Profile
It is generally well-tolerated in clinical studies. Reported side effects are rare and mild:
- Headache
- Dizziness
- Skin irritation at application site
No significant hormonal effects have been observed – unlike parent compound ACTH, Semax does not affect cortisol.
The Bottom Line
This peptide stands out among nootropics because it doesn’t just stimulate the brain temporarily – it promotes long-term neuroplasticity through BDNF upregulation. Combined with its effects on dopamine, serotonin, and gene expression, Semax offers a sophisticated approach to cognitive enhancement and neuroprotection.
Disclaimer: This article is for educational purposes only. NexGen Peptides products are intended for laboratory research use only. Not for human consumption.
References:
- Dolotov OV, et al. Semax, an analog of ACTH(4-10), regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006.
- Eremin KO, et al. Semax activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005.
- Kolbaev SN, et al. Effect of Semax on intracellular calcium dynamics in rat brain neurons. Bull Exp Biol Med. 2025.